imiquimod has been researched along with pep005 in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 24 (72.73) | 24.3611 |
| 2020's | 9 (27.27) | 2.80 |
| Authors | Studies |
|---|---|
| Gaspari, AA; Grossberg, AL | 1 |
| Frankel, A; Goldenberg, G | 1 |
| Sullivan, TJ | 1 |
| Gupta, AK; Paquet, M | 1 |
| Calzavara Pinton, P; Catricalà, C; Neri, L; Pellacani, G; Peris, K; Peserico, A; Pimpinelli, N | 1 |
| Sligh, JE | 1 |
| Alarcon, I; Sibbring, GC; Stockfleth, E | 1 |
| Isoherranen, K; Koskenmies, S; Overmark, M; Pitkänen, S; Saksela, O; Ylitalo, L | 1 |
| Erdmann, R; Jacobs, A; Nast, A; Rosumeck, S; Sporbeck, B; Werner, RN | 1 |
| Caglia, M; Hashemi, P; Kim, C; Shulman, K | 1 |
| Gilaberte, Y; González, S; Gracia-Cazaña, T | 1 |
| Athanasakis, K; Boubouchairopoulou, N; Kontodimas, S; Kyriopoulos, J; Tarantilis, F; Tsiantou, V | 1 |
| Holmstrup, H; Jemec, GBE; Malmberg, I; Norlin, JM; Norrlid, H; Ragnarson Tennvall, G; Sartorius, K; Thormann, H | 1 |
| De Felici, MB; Feliciani, C; Pagliarello, C; Rovesti, M; Satolli, F; Zucchi, A | 1 |
| da Motta, VRV; de Oliveira, ECV; Galadari, H; Ilha, CSO; Leonardi, GR; Magalhães, RF; Pantoja, PC | 1 |
| Almazan-Fernandez, FM; Husein-ElAhmed, H; Husein-ElAhmed, S | 1 |
| Calzavara-Pinton, P; Hamon, P; Tanova, N | 1 |
| Caruntu, C; Constantin, MM; Draghici, CC; Lisievici, CV; Lupu, M; Popa, AV; Sebe, TI; Solomon, I; Vajaitu, C; Voiculescu, VM | 1 |
| Arits, AHMM; Essers, BAB; Jansen, MHE; Kelleners-Smeets, NWJ; Kessels, JPHM; Kouloubis, N; Mosterd, K; Nelemans, PJ; Quaedvlieg, PJF; Steijlen, PM; van Pelt, HPA | 1 |
| Council, ML; Nemer, KM | 1 |
| Herms, F | 1 |
| Kircik, LH | 1 |
| Collins, A; Doerfler, L; Savas, J | 1 |
| Bae, KN; Kim, BS; Kim, HS; Kim, MB; Ko, HC; Shin, K | 1 |
| Becker, L; Berking, C; French, LE; Heppt, MV; Kohl, C; Steeb, T | 1 |
| Boyle, GM; Cullen, JK; Parsons, PG; Simmons, JL | 1 |
| Essers, BAB; Jansen, MHE; Kelleners-Smeets, NWJ; Kessels, JPHM; Merks, I; Mosterd, K; Nelemans, PJ | 1 |
| Berking, C; Heppt, MV; Steeb, T | 1 |
| Ali, FR; Raza, SA | 1 |
| Dunkelly-Allen, N; Feldman, SR; Hansen, JB; Larsson, T; Veverka, KA | 1 |
| Baker, C; MacMahon, B; Sinclair, R; Spelman, L; Supranowicz, M | 1 |
| Feldman, SR; Heron, CE | 1 |
| Ahmady, S; Essers, BAB; Jansen, MHE; Kelleners-Smeets, NWJ; Kessels, JPHM; Mosterd, K; Nelemans, PJ | 1 |
13 review(s) available for imiquimod and pep005
| Article | Year |
|---|---|
Topical antineoplastic agents in the treatment of mucocutaneous diseases.
Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Diterpenes; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Mucositis; Mucous Membrane; Skin Diseases; Skin Neoplasms | 2011 |
Topical therapies for periorbital cutaneous malignancies: indications and treatment regimens.
Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Diterpenes; Fluorouracil; Humans; Imiquimod; Mitomycin; Orbital Neoplasms; Skin Neoplasms | 2012 |
Network meta-analysis of the outcome 'participant complete clearance' in nonimmunosuppressed participants of eight interventions for actinic keratosis: a follow-up on a Cochrane review.
Topics: Adjuvants, Immunologic; Aged; Aminolevulinic Acid; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Cryotherapy; Diclofenac; Diterpenes; Drug Combinations; Female; Fluorouracil; Follow-Up Studies; Humans; Hyaluronic Acid; Imiquimod; Immunocompetence; Immunosuppressive Agents; Keratosis, Actinic; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Randomized Controlled Trials as Topic; Treatment Outcome | 2013 |
New therapeutic options for actinic keratosis and basal cell carcinoma.
Topics: Aminoquinolines; Anilides; Antineoplastic Agents; Carcinoma, Basal Cell; Cryosurgery; Diterpenes; Humans; Imiquimod; Keratosis, Actinic; Mutation; Patched Receptors; Pyridines; Receptors, Cell Surface; Skin Neoplasms; Treatment Outcome | 2014 |
New Topical Treatment Options for Actinic Keratosis: A Systematic Review.
Topics: Administration, Cutaneous; Aminoquinolines; Dermatologic Agents; Diterpenes; Drug Combinations; Facial Dermatoses; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Randomized Controlled Trials as Topic; Salicylic Acid; Scalp Dermatoses; Skin; Treatment Outcome | 2016 |
[Diagnosis and treatment of actinic keratosis].
Topics: Administration, Topical; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Cryotherapy; Diclofenac; Diterpenes; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Laser Therapy; Photochemotherapy; Precancerous Conditions; Primary Health Care | 2015 |
Resistance of Nonmelanoma Skin Cancer to Nonsurgical Treatments. Part I: Topical Treatments.
Topics: Adjuvants, Immunologic; Administration, Cutaneous; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Antigen-Presenting Cells; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma; Clinical Trials as Topic; Dermatologic Agents; Diclofenac; Diterpenes; Drug Resistance, Neoplasm; Fluorouracil; Humans; Imiquimod; Meta-Analysis as Topic; Neoplasm Proteins; Neoplastic Stem Cells; Skin Neoplasms | 2016 |
Actinic keratosis - review for clinical practice.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites, Antineoplastic; Antineoplastic Agents; Cryotherapy; Diclofenac; Diterpenes; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Photochemotherapy; Retinoids | 2019 |
Mediators of Inflammation in Topical Therapy of Skin Cancers.
Topics: Administration, Topical; Aminoquinolines; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Cytokines; Diterpenes; Fluorouracil; Humans; Imiquimod; Inflammation; Melanoma; Neoplasm Metastasis; Skin; Skin Neoplasms; Toll-Like Receptor 7 | 2019 |
Topical and Systemic Modalities for Chemoprevention of Nonmelanoma Skin Cancer.
Topics: Administration, Cutaneous; Administration, Oral; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Chemoprevention; Cyclooxygenase Inhibitors; Diclofenac; Diterpenes; Fluorouracil; Humans; Imiquimod; Niacinamide; Photochemotherapy; Retinoids; Skin Neoplasms | 2019 |
Nonsurgical Treatments for Nonmelanoma Skin Cancer.
Topics: Administration, Cutaneous; Anilides; Antineoplastic Agents; Antineoplastic Agents, Immunological; Biphenyl Compounds; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cryosurgery; Cyclooxygenase Inhibitors; Diclofenac; Diterpenes; Fluorouracil; Humans; Imiquimod; Photochemotherapy; Programmed Cell Death 1 Receptor; Pyridines; Radiotherapy; Skin Neoplasms; Watchful Waiting | 2019 |
Topical treatments for skin cancer.
Topics: Administration, Cutaneous; Antineoplastic Agents; Carcinoma, Basal Cell; Clinical Trials as Topic; Diterpenes; Drug Delivery Systems; Fluorouracil; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Keratosis, Actinic; Melanoma; Neoplasms, Squamous Cell; Photochemotherapy; Retinoids; Skin; Skin Neoplasms; Ultraviolet Rays | 2020 |
A review of actinic keratosis, skin field cancerisation and the efficacy of topical therapies.
Topics: Antineoplastic Agents; Diclofenac; Disease Progression; Diterpenes; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Photochemotherapy; Recurrence; Skin Neoplasms | 2021 |
4 trial(s) available for imiquimod and pep005
| Article | Year |
|---|---|
Randomized Trial of Four Treatment Approaches for Actinic Keratosis.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Diterpenes; Female; Fluorouracil; Follow-Up Studies; Gels; Humans; Imiquimod; Intention to Treat Analysis; Keratosis, Actinic; Male; Middle Aged; Patient Compliance; Photochemotherapy; Photosensitizing Agents; Proportional Hazards Models; Scalp Dermatoses; Single-Blind Method; Skin Cream; Treatment Outcome | 2019 |
Ingenol mebutate gel for the treatment of molluscum contagiosum: An open-label comparative pilot study.
Topics: Antineoplastic Agents; Child; Child, Preschool; Diterpenes; Female; Gels; Humans; Imiquimod; Infant; Male; Molluscum Contagiosum; Pilot Projects; Skin Cream; Time Factors | 2020 |
A trial-based cost-effectiveness analysis of topical 5-fluorouracil vs. imiquimod vs. ingenol mebutate vs. methyl aminolaevulinate conventional photodynamic therapy for the treatment of actinic keratosis in the head and neck area performed in the Netherla
Topics: Aminolevulinic Acid; Cost-Benefit Analysis; Diterpenes; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Netherlands; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Treatment Outcome | 2020 |
The Effect of Four Approaches to Treat Actinic Keratosis on the Health-Related QOL, as Assessed by the Skindex-29 and Actinic Keratosis QOL.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Diterpenes; Female; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Male; Patient Reported Outcome Measures; Photochemotherapy; Quality of Life; Skin Cream; Surveys and Questionnaires; Treatment Outcome | 2021 |
16 other study(ies) available for imiquimod and pep005
| Article | Year |
|---|---|
What's new in the treatment of actinic keratoses?
Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Cryotherapy; Diterpenes; Humans; Imiquimod; Keratosis, Actinic; Photochemotherapy; Skin Neoplasms | 2011 |
Key Opinion Leader (KOL) Consensus for actinic keratosis management in Italy: the AKTUAL Workshop.
Topics: Aminoquinolines; Carcinoma, Squamous Cell; Case Management; Clinical Trials as Topic; Cryosurgery; Diagnosis, Differential; Diclofenac; Disease Management; Disease Progression; Diterpenes; Fluorouracil; Humans; Imiquimod; Italy; Keratosis, Actinic; Laser Therapy; Neoplasms, Radiation-Induced; Photochemotherapy; Practice Guidelines as Topic; Skin Neoplasms; Sunscreening Agents; United Kingdom; United States; Watchful Waiting | 2013 |
Methods and Results Report - Evidence and consensus-based (S3) Guidelines for the Treatment of Actinic Keratosis -International League of Dermatological Societies in cooperation with the European Dermatology Forum.
Topics: Aminoquinolines; Antineoplastic Agents; Combined Modality Therapy; Cryotherapy; Curettage; Cyclooxygenase Inhibitors; Diclofenac; Diterpenes; Evidence-Based Medicine; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Laser Therapy; Lasers, Gas; Photochemotherapy | 2015 |
Treatment of Imiquimod Resistant Epidermodysplasia Verruciformis With Ingenol Mebutate.
Topics: Acitretin; Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Diterpenes; Drug Resistance; Epidermodysplasia Verruciformis; Female; Gels; Humans; Imiquimod; Keratolytic Agents; Rare Diseases; Skin Neoplasms; Treatment Outcome; Tretinoin | 2016 |
Cost-effectiveness of Ingenol Mebutate Gel for the Treatment of Actinic Keratosis in Greece.
Topics: Aminoquinolines; Cost-Benefit Analysis; Diclofenac; Diterpenes; Greece; Humans; Imiquimod; Keratosis, Actinic; Quality-Adjusted Life Years | 2017 |
Patient-reported outcomes in topical field treatment of actinic keratosis in Swedish and Danish patients.
Topics: Administration, Topical; Aged; Aminoquinolines; Denmark; Diclofenac; Diterpenes; Drug Administration Schedule; Female; Humans; Imiquimod; Keratosis, Actinic; Male; Middle Aged; Patient Reported Outcome Measures; Patient Satisfaction; Quality of Life; Surveys and Questionnaires; Sweden | 2018 |
Multiple Basal Cell Carcinoma Arising in a Verrucous Epidermal Naevus: Clinical, Histological and Therapeutic Observations.
Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Cryotherapy; Diterpenes; Female; Gels; Humans; Imiquimod; Neoplasms, Multiple Primary; Nevus, Sebaceous of Jadassohn; Skin Neoplasms; Treatment Outcome | 2018 |
Ingenol mebutate versus imiquimod versus diclofenac for actinic cheilitis: a 6-month follow-up clinical study.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Cheilitis; Diclofenac; Diterpenes; Female; Follow-Up Studies; Humans; Imiquimod; Male; Middle Aged | 2019 |
Evaluation of the treatment costs and duration of topical treatments for multiple actinic keratosis based on the area of the cancerization field and not on the number of lesions.
Topics: Administration, Topical; Aminolevulinic Acid; Cohort Studies; Cost of Illness; Diclofenac; Diterpenes; Drug Administration Schedule; Female; Fluorouracil; Health Care Costs; Humans; Imiquimod; Italy; Keratosis, Actinic; Male; Photochemotherapy; Precancerous Conditions; Retrospective Studies; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2019 |
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Cost-Benefit Analysis; Cryotherapy; Dermatologic Agents; Diclofenac; Diterpenes; Electrocoagulation; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Laser Therapy; Photochemotherapy | 2019 |
Addressing the Challenges of Treating Actinic Keratosis
Topics: Dermatologic Agents; Disease Progression; Diterpenes; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Photochemotherapy | 2019 |
Long-term efficacy of interventions for actinic keratosis: protocol for a systematic review and network meta-analysis.
Topics: Adjuvants, Immunologic; Disease Progression; Diterpenes; Europe; Humans; Imiquimod; Keratosis, Actinic; Meta-Analysis as Topic; Network Meta-Analysis; Photochemotherapy; Randomized Controlled Trials as Topic; Systematic Reviews as Topic | 2019 |
Cash is king: the balance of costs and effectiveness of treatments for actinic keratosis.
Topics: Aminolevulinic Acid; Cost-Benefit Analysis; Diterpenes; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Netherlands; Photochemotherapy | 2020 |
Comparison of efficacy of field treatments for actinic keratoses.
Topics: Adult; Aminolevulinic Acid; Diterpenes; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Photochemotherapy; Scalp Dermatoses | 2020 |
Real-World Effectiveness and Safety of Field- and Lesion-Directed Treatments for Actinic Keratosis.
Topics: Administration, Cutaneous; Aged; Antineoplastic Agents; Combined Modality Therapy; Cryotherapy; Diterpenes; Female; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Male; Middle Aged; Retrospective Studies; Severity of Illness Index; Skin; Treatment Outcome; United States | 2020 |
Ingenol Mebutate and the Treatment of Actinic Keratosis.
Topics: Aminolevulinic Acid; Carcinoma, Squamous Cell; Clinical Trials as Topic; Diterpenes; Fluorouracil; Humans; Imiquimod; Incidence; Keratosis, Actinic; Patient Preference; Photochemotherapy; Photosensitizing Agents; Risk Assessment; Skin Neoplasms; Treatment Outcome | 2021 |